Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Aberrant protein glycosylation is well known hallmark of cancer and represents a promising source of potential new biomarkers. At Glycodots we actively working on novel rapid diagnostics for the detection of breast, liver and pancreatic cancers using novel glycobiomarkers that are exceptionally specific.
Copyright © 2009-2024 Glycodots LLC - All Rights Reserved.
Powered by Science
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.